Leukemia Home > Tasigna Medication Information

Adults who have been diagnosed with chronic myeloid leukemia (CML) may benefit from Tasigna® (nilotinib). This medicine can help slow down the progression of the leukemia by blocking certain proteins in the body that the cancer cells need to grow and multiply.
Tasigna comes in the form of a capsule that is taken twice daily, with 12 hours between doses. Your specific dosage will depend on how you respond to the medicine, whether you are taking other medications, and other factors.
Before starting treatment with Tasigna, make sure to review the medication's safety information with your healthcare provider. For example, you may not be able to use this drug if you have an irregular heartbeat, heart disease, or a history of pancreatitis. Also, this drug may react with certain other medications.
(For more information on this medication, click Tasigna. This article offers a complete overview on this drug, including details on side effects, dosing guidelines, effectiveness, and more.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2018 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.